CENTOCOR, INC.
🇺🇸United States
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2014-09-05
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 637
- Registration Number
- NCT00264537
A Long-term Safety Study of Infliximab (Remicade)
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-12-06
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 2971
- Registration Number
- NCT00261976
A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2013-08-19
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT00246012
A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 607
- Registration Number
- NCT00236028
A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-10-03
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 249
- Registration Number
- NCT00230529
A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 112
- Registration Number
- NCT00207675
A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 306
- Registration Number
- NCT00207766
An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 172
- Registration Number
- NCT00207714
A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-04-23
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 249
- Registration Number
- NCT00207727
A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Centocor, Inc.
- Target Recruit Count
- 279
- Registration Number
- NCT00207701
© Copyright 2024. All Rights Reserved by MedPath